Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C DeVito

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin SignalingNicholas C DeVito, Y-Van Nguyen, Michael Sturdivant, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 27, 2022
Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse EventsCameron J Oswalt, Rami N Al-Rohil, Bala Theivanthiran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cellsC Devito, K Broliden, R Kaul, et al.
Cancer Research|February 19, 2025
GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin SignalingNicholas C DeVito, Y-Van Nguyen, Michael Sturdivant, et al.
Cell Reports|May 5, 2021
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapyNicholas C DeVito, Michael Sturdivant, Balamayooran Thievanthiran, et al.
AME Case Reports|April 29, 2021
A case report of microsatellite instability (MSI)-high, <i>HER2</i> amplified pancreatic adenocarcinoma with central nervous system metastasisNicholas C DeVito, Colm Kelleher, Kyle C Strickland, et al.
Science Translational Medicine|November 23, 2022
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapyBalamayooran Theivanthiran, Nagendra Yarla, Tarek Haykal, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Tumor <i>NLRP3</i> Amplification Promotes Immunotherapy Resistance by Suppressing MHC Class I ExpressionBala Theivanthiran, Nagendra Yarla, Kaylee Villareal, et al.
The Journal of Clinical Investigation|February 5, 2020
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapyBalamayoora Theivanthiran, Kathy S Evans, Nicholas C DeVito, et al.
Cancer Medicine|September 15, 2023
Assessing the utility of molecular diagnostic classification for cancers of unknown primaryElle C Moore, Gerard C Blobe, Nicholas C DeVito, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin SignalingNicholas C DeVito, Y-Van Nguyen, Michael Sturdivant, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 27, 2022
Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse EventsCameron J Oswalt, Rami N Al-Rohil, Bala Theivanthiran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cellsC Devito, K Broliden, R Kaul, et al.
Cancer Research|February 19, 2025
GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin SignalingNicholas C DeVito, Y-Van Nguyen, Michael Sturdivant, et al.
Cell Reports|May 5, 2021
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapyNicholas C DeVito, Michael Sturdivant, Balamayooran Thievanthiran, et al.
AME Case Reports|April 29, 2021
A case report of microsatellite instability (MSI)-high, <i>HER2</i> amplified pancreatic adenocarcinoma with central nervous system metastasisNicholas C DeVito, Colm Kelleher, Kyle C Strickland, et al.
Science Translational Medicine|November 23, 2022
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapyBalamayooran Theivanthiran, Nagendra Yarla, Tarek Haykal, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Tumor <i>NLRP3</i> Amplification Promotes Immunotherapy Resistance by Suppressing MHC Class I ExpressionBala Theivanthiran, Nagendra Yarla, Kaylee Villareal, et al.
The Journal of Clinical Investigation|February 5, 2020
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapyBalamayoora Theivanthiran, Kathy S Evans, Nicholas C DeVito, et al.
Cancer Medicine|September 15, 2023
Assessing the utility of molecular diagnostic classification for cancers of unknown primaryElle C Moore, Gerard C Blobe, Nicholas C DeVito, et al.
Pageof 4